Clinical Trial Update: Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Sofosbuvir plus Simeprevir to Sofosbuvir plus Ribavirin for Hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Ain Shams University | Conditions: HCV | Phase 4 | Status: COMPLETED